Nanoparticles: alternatives against drug-resistant pathogenic microbes

Antimicrobial substances may be synthetic, semisynthetic, or of natural origin (i.e., from plants and animals). Antimicrobials are considered “miracle drugs” and can determine if an infected patient/animal recovers or dies. However, the misuse of antimicrobials has led to the development of multi-dr...

Full description

Bibliographic Details
Main Authors: Rudramurthy, Gudepalya Renukaiah, Swamy, Mallappa Kumara, Sinniah, Uma Rani, Ghasemzadeh, Ali
Format: Article
Language:English
Published: M D P I AG 2016
Online Access:http://psasir.upm.edu.my/id/eprint/53362/
http://psasir.upm.edu.my/id/eprint/53362/1/Nanoparticles.pdf
_version_ 1848852262480248832
author Rudramurthy, Gudepalya Renukaiah
Swamy, Mallappa Kumara
Sinniah, Uma Rani
Ghasemzadeh, Ali
author_facet Rudramurthy, Gudepalya Renukaiah
Swamy, Mallappa Kumara
Sinniah, Uma Rani
Ghasemzadeh, Ali
author_sort Rudramurthy, Gudepalya Renukaiah
building UPM Institutional Repository
collection Online Access
description Antimicrobial substances may be synthetic, semisynthetic, or of natural origin (i.e., from plants and animals). Antimicrobials are considered “miracle drugs” and can determine if an infected patient/animal recovers or dies. However, the misuse of antimicrobials has led to the development of multi-drug-resistant bacteria, which is one of the greatest challenges for healthcare practitioners and is a significant global threat. The major concern with the development of antimicrobial resistance is the spread of resistant organisms. The replacement of conventional antimicrobials by new technology to counteract antimicrobial resistance is ongoing. Nanotechnology-driven innovations provide hope for patients and practitioners in overcoming the problem of drug resistance. Nanomaterials have tremendous potential in both the medical and veterinary fields. Several nanostructures comprising metallic particles have been developed to counteract microbial pathogens. The effectiveness of nanoparticles (NPs) depends on the interaction between the microorganism and the NPs. The development of effective nanomaterials requires in-depth knowledge of the physicochemical properties of NPs and the biological aspects of microorganisms. However, the risks associated with using NPs in healthcare need to be addressed. The present review highlights the antimicrobial effects of various nanomaterials and their potential advantages, drawbacks, or side effects. In addition, this comprehensive information may be useful in the discovery of broad-spectrum antimicrobial drugs for use against multi-drug-resistant microbial pathogens in the near future.
first_indexed 2025-11-15T10:35:17Z
format Article
id upm-53362
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T10:35:17Z
publishDate 2016
publisher M D P I AG
recordtype eprints
repository_type Digital Repository
spelling upm-533622017-10-24T03:58:44Z http://psasir.upm.edu.my/id/eprint/53362/ Nanoparticles: alternatives against drug-resistant pathogenic microbes Rudramurthy, Gudepalya Renukaiah Swamy, Mallappa Kumara Sinniah, Uma Rani Ghasemzadeh, Ali Antimicrobial substances may be synthetic, semisynthetic, or of natural origin (i.e., from plants and animals). Antimicrobials are considered “miracle drugs” and can determine if an infected patient/animal recovers or dies. However, the misuse of antimicrobials has led to the development of multi-drug-resistant bacteria, which is one of the greatest challenges for healthcare practitioners and is a significant global threat. The major concern with the development of antimicrobial resistance is the spread of resistant organisms. The replacement of conventional antimicrobials by new technology to counteract antimicrobial resistance is ongoing. Nanotechnology-driven innovations provide hope for patients and practitioners in overcoming the problem of drug resistance. Nanomaterials have tremendous potential in both the medical and veterinary fields. Several nanostructures comprising metallic particles have been developed to counteract microbial pathogens. The effectiveness of nanoparticles (NPs) depends on the interaction between the microorganism and the NPs. The development of effective nanomaterials requires in-depth knowledge of the physicochemical properties of NPs and the biological aspects of microorganisms. However, the risks associated with using NPs in healthcare need to be addressed. The present review highlights the antimicrobial effects of various nanomaterials and their potential advantages, drawbacks, or side effects. In addition, this comprehensive information may be useful in the discovery of broad-spectrum antimicrobial drugs for use against multi-drug-resistant microbial pathogens in the near future. M D P I AG 2016 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/53362/1/Nanoparticles.pdf Rudramurthy, Gudepalya Renukaiah and Swamy, Mallappa Kumara and Sinniah, Uma Rani and Ghasemzadeh, Ali (2016) Nanoparticles: alternatives against drug-resistant pathogenic microbes. Molecules, 21 (7). pp. 1-30. ISSN 1420-3049 http://www.mdpi.com/1420-3049/21/7/836 10.3390/molecules21070836
spellingShingle Rudramurthy, Gudepalya Renukaiah
Swamy, Mallappa Kumara
Sinniah, Uma Rani
Ghasemzadeh, Ali
Nanoparticles: alternatives against drug-resistant pathogenic microbes
title Nanoparticles: alternatives against drug-resistant pathogenic microbes
title_full Nanoparticles: alternatives against drug-resistant pathogenic microbes
title_fullStr Nanoparticles: alternatives against drug-resistant pathogenic microbes
title_full_unstemmed Nanoparticles: alternatives against drug-resistant pathogenic microbes
title_short Nanoparticles: alternatives against drug-resistant pathogenic microbes
title_sort nanoparticles: alternatives against drug-resistant pathogenic microbes
url http://psasir.upm.edu.my/id/eprint/53362/
http://psasir.upm.edu.my/id/eprint/53362/
http://psasir.upm.edu.my/id/eprint/53362/
http://psasir.upm.edu.my/id/eprint/53362/1/Nanoparticles.pdf